title: Genetic defect in human X-linked agammaglobulinemia impedes a maturational evolution of pro-B cells into a later stage of pre-B cells in the B-cell differentiation pathway.
abstract: Surrogate light chains (lambda 5/VpreB) are selectively expressed in early precursors of B cells. B-cell defects in X-linked agammaglobulinemia (XLA) are caused by mutations in the gene for Bruton's tyrosine kinase. To elucidate the nature of early B-lineage cells in bone marrow (BM), samples from 13 XLA patients and 24 healthy controls of different ages were comparatively analyzed using an antihuman VpreB monoclonal antibody. Expression of surrogate light (SL) and mu-heavy chains were examined after cell membrane permeabilization because they are mainly expressed in the cytoplasm of early B-lineage cells. A flow cytometric analysis of normal BM identified 5 discrete cell types of B cells: mu(-)SL(++) (pro-B [B-cell progenitor]), mu(low)SL(++) (pre-B1a), mu(low)SL(+) (pre-B1b), mu(low)SL(- )(pre-B2), and mu(high)SL(- )(B). The large cells, presumably in cycling states, were enriched in pre-B1a cells. The frequencies of B-lineage cells in BM were higher in young children, and declined with advancing age. In contrast, XLA showed a profound reduction in BM B-lineage cells. In XLA BM, an expansion of pro-B cells with some small pre-B1a cells was marked, but other cells were negligible. These observations illustrate a B-cell maturation defect in XLA as well as a normal human B-cell differentiation pathway. The results suggest that the genetic defect in XLA may impede the evolution of pro-B cells beyond the earlier pre-B stage into the later stage of pre-B cells in B-cell development. (Blood. 2000;96:610-617)
authors.affiliation: Department of Pediatrics at the Faculty of Medicine, Toyama Medical and Pharmaceutical University, the Toyama Red Cross Hospital, Japan.
authors.forename: K
authors.initials: K
authors.lastname: Nomura
authors.forename: H
authors.initials: H
authors.lastname: Kanegane
authors.forename: H
authors.initials: H
authors.lastname: Karasuyama
authors.forename: S
authors.initials: S
authors.lastname: Tsukada
authors.forename: K
authors.initials: K
authors.lastname: Agematsu
authors.forename: G
authors.initials: G
authors.lastname: Murakami
authors.forename: S
authors.initials: S
authors.lastname: Sakazume
authors.forename: M
authors.initials: M
authors.lastname: Sako
authors.forename: R
authors.initials: R
authors.lastname: Tanaka
authors.forename: Y
authors.initials: Y
authors.lastname: Kuniya
authors.forename: T
authors.initials: T
authors.lastname: Komeno
authors.forename: S
authors.initials: S
authors.lastname: Ishihara
authors.forename: K
authors.initials: K
authors.lastname: Hayashi
authors.forename: T
authors.initials: T
authors.lastname: Kishimoto
authors.forename: T
authors.initials: T
authors.lastname: Miyawaki
mesh_terms: D000293:Adolescent; D000328:Adult; D000361:Agammaglobulinemia / Q000235:genetics*; D000375:Aging; D001402:B-Lymphocytes / Q000473:pathology*; D001854:Bone Marrow Cells / Q000473:pathology; D002454:Cell Differentiation; D002648:Child; D002675:Child, Preschool; D005434:Flow Cytometry; D008040:Genetic Linkage; D006801:Humans; D007223:Infant; D018655:Lymphocyte Count; D009154:Mutation; D011505:Protein-Tyrosine Kinases / Q000235:genetics; D013234:Stem Cells / Q000473:pathology*; D014960:X Chromosome
chemical_list: D011505:Protein-Tyrosine Kinases